My Insights

• Google DeepMind wins joint Nobel Prize in Chemistry for the use of AI in predicting protein structures
• Predicting protein structures using AI has brought significant advance our understanding of proteins
• Using AI in Biotech industry could innovate and outperform previous research methods
• AI Bio tech corps such as Recursion Pharms, CRISPR Theerapeutics might have upside potential in near future when AI tech is more closely commertialized

Miscellaneous Thoughts

• ToolGen, listed in KOSDAQ, is CRISPR CAS9 IP holding company, and undergoing IP law suit
• CRISPR/Cas9, gene editing tech, won the 2020 Nobel Prize and two female researchers who won the prize founded gene editing tech companies each. (CRISPR Therapeutics, Intellia Therapeutics)
• CRIDPR/Cas9 tech can cure damaged gene permernantly, so monetizing recurring revenue is questionable

Summary

“What is the Nobel Prize in Chemistry Created by Google AI?” features Professor Baek Min-kyung from Seoul National University discussing the groundbreaking achievement of the Nobel Prize awarded for the use of AI in predicting protein structures. The overarching theme emphasizes the significance of AI in advancing our understanding of proteins, which are crucial for biological functions and disease treatment, showcasing how this innovation can revolutionize drug development and scientific research. The discussion highlights the collaboration between AI experts and biochemists, leading to a transformative approach in the field of chemistry.